{
    "Trade/Device Name(s)": [
        "Sofia Lyme FIA",
        "Sofia 2 analyzer",
        "Sofia 2 Installation Pack"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K173691",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122979",
        "K122986"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSR"
    ],
    "Summary Letter Date": "November 29, 2017",
    "Summary Letter Received Date": "December 1, 2017",
    "Submission Date": "November 29, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "microbiology"
    ],
    "Analyte(s)": [
        "IgM antibodies to Borrelia burgdorferi",
        "IgG antibodies to Borrelia burgdorferi"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Sofia analyzer",
        "Sofia 2 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescence",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Qualitative antibody detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Kit",
        "Installation Pack"
    ],
    "Document Summary": "FDA 510(k) summary for Sofia Lyme FIA immunofluorescence lateral flow assay detecting IgM and IgG antibodies to Borrelia burgdorferi using Sofia/Sofia 2 analyzers",
    "Indications for Use Summary": "Aid in diagnosis of Lyme disease by rapid qualitative detection of human IgM and IgG antibodies to Borrelia burgdorferi from serum and plasma specimens; results used in conjunction with clinical evaluation and other diagnostics; all positive results require confirmatory western blot testing",
    "fda_folder": "Microbiology"
}